All filters
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance
L. Kostrikis Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence
A. Antonova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple
A. Bergna  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
M. Alkhatib Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? - Dr. Jürgen Rockstroh Con Standpoint -
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Videos
Long-Acting Therapies: Which Patients Will Benefit Most? - Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Videos
HIV and COVID-19 co-infection: An update - Dr. Cristiana Oprea
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Managing Highly Treatment-Experienced Patients - Prof. Anca Streinu Cercel -
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph Boesecke
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
STI Diagnostics in the CEE Region - Pawel Jakubowski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
2020: Have We Reached the 90-90-90 Targets? - Teymur Noori
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
HIV and COVID-19 co-infection: An update Cristiana Oprea
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers? Prof. Milosz Parczewski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? Con Standpoint - Jürgen Rockstroh
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020